{"schema_version":"secwatch.filing_event.v1","accession":"0001638833-24-000110","form_type":"8-K","ticker":"SGRY","cik":"0001638833","company_name":"Surgery Partners, Inc.","filed_at":"2024-05-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:19.372506+00:00","generated_at":"2026-06-02T18:46:33.729074+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Surgery Partners Q1 revenue up 7.7% to $717.4M, Adjusted EBITDA $97.5M; raises FY outlook","bullets":["Net loss $12.4M; Adjusted EBITDA $97.5M (+8.2% YoY); margin 13.6%.","Same-facility revenue +10.2% YoY with 8.8% revenue per case increase and 1.3% case growth.","FY 2024 guidance raised: revenue at least $3.05B, Adjusted EBITDA at least $505M.","Completed refinancing of term loan and unsecured notes; no material debt maturities until 2030.","Cash $185.2M; revolver capacity $607.3M; net debt/EBITDA ratio ~3.5x."],"urls":{"canonical":"https://secwatch.observer/filing/0001638833-24-000110","json":"https://secwatch.observer/filing/0001638833-24-000110.json","markdown":"https://secwatch.observer/filing/0001638833-24-000110.md","text":"https://secwatch.observer/filing/0001638833-24-000110.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1638833/000163883324000110/0001638833-24-000110-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1638833/000163883324000110/sgry-20240507.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-02T18:46:33.729074+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"3c18f1baafbddf540ba372419abb660cfba49846","claim":"Surgery Partners, Inc. reported full year 2024 results: revenue at least $3.05 billion. Guidance raised.","evidence_excerpt":"The Company raised its outlook for 2024 revenues to be at least $3.05 billion and projects 2024 Adjusted EBITDA to be at least $505 million.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1638833/000163883324000110/0001638833-24-000110-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"full year 2024"},{"label":"Revenue","value":"at least $3.05 billion"},{"label":"Guidance","value":"raised"},{"label":"Result","value":"guidance update"}],"fact_type":"earnings_release"},{"claim_id":"9eb7a2cef0f272abad73000362d2c33923de343a","claim":"Surgery Partners, Inc. reported three months ended March 31, 2024 results: revenue $717.4 million, net income -$12.4 million.","evidence_excerpt":"• Revenues increased 7.7% to $717.4 million compared to the prior year period ◦ Same-facility revenues increased 10.2% • Net loss attributable to Surgery Partners, Inc. was $12.4 million","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1638833/000163883324000110/0001638833-24-000110-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"three months ended March 31, 2024"},{"label":"Revenue","value":"$717.4 million"},{"label":"Net income","value":"-$12.4 million"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}